Bristol-Myers Squibb Company: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI Risk Brief Interpretation layer — deterministic data below

Bristol-Myers added ESG disclosure risk and intensified IT security, pricing, and regulatory exposure concerns in 2024.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
0
Removed
7
Modified
15
Unchanged
🟢 New in Current Filing Disclosure change8/10

Expectations relating to environmental, social and governance considerations and related reporting obligations expose the Company to potential liabilities, increased costs, reputational harm, and other adverse effects on the Company’s business.

🟡 Modified Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins. 🔒
🟡 Modified We are dependent on information technology systems and face risk of cybersecurity incidents that could disrupt our business and result in theft of proprietary and confidential information. 🔒
🟡 Modified We are subject to a variety of U.S. and international laws and regulations. 🔒

And 4 more changes in the full comparison.

7 changes in this historical filing

The complete historical comparison (2024 vs 2023) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →